Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Res Toxicol ; 36(8): 1255-1266, 2023 08 21.
Article in English | MEDLINE | ID: mdl-37435843

ABSTRACT

Deferasirox (DFS) is used for the treatment of iron accumulation caused by the need for long-term blood transfusions, such as thalassemia or other rare anemia. Liver injury due to exposure to DFS has been documented, and the toxic mechanisms of DFS are unknown. The present study aimed to investigate the reactive metabolites of DFS in vitro and in vivo to help us understand the mechanisms of DFS hepatotoxicity. Two hydroxylated metabolites (5-OH and 5'-OH) were identified during incubation of DFS-supplemented rat liver microsomes. Such microsomal incubations fortified with glutathione (GSH) or N-acetylcysteine (NAC) as capture agents offered two GSH conjugates and two NAC conjugates. These GSH conjugates and NAC conjugates were also detected in bile and urine of rats given DFS. CYP1A2 and CYP3A4 were found to dominate the metabolic activation of DFS. Administration of DFS induced decreased cell survival in cultured primary hepatocytes. Pretreatment with ketoconazole and 1-aminobenzotrizole made hepatocytes less susceptible to the cytotoxicity of DFS.


Subject(s)
Hepatocytes , Liver , Rats , Animals , Activation, Metabolic , Deferasirox/pharmacology , Deferasirox/metabolism , Liver/metabolism , Hepatocytes/metabolism , Microsomes, Liver/metabolism , Acetylcysteine/metabolism , Glutathione/metabolism
2.
Chem Biol Interact ; 382: 110628, 2023 Sep 01.
Article in English | MEDLINE | ID: mdl-37442290

ABSTRACT

Metaxalone (MTX) is a central nervous system (CNS) depressant used for the treatment of acute skeletal muscle pain. Several cases of fatal overdose deaths in the clinical use of MTX, along with the presence of ischemic hepatitis in deceased patients, have been documented. The present study aimed to investigate the metabolic activation of MTX and to define the possible correlation between the metabolic activation and cytotoxicity of MTX. An oxidative metabolite (M1) and a GSH conjugate (M2) were observed in S9 fraction incubations as well as in rat primary hepatocyte culture after exposure to MTX. M1 and M2 were also observed in bile of MTX-treated rats. CYP2A6 was found to dominate the oxidation of MTX. Both methoxsalen (MTS, a CYP2A6 inhibitor) and 2,6-dichloro-4-nitrophenol (DCNP, a sulfotransferase inhibitor) dramatically decreased the formation of M2. Pre-treatment of primary hepatocytes with DCNP or MTS significantly decreased the susceptibility to the cytotoxicity of MTX.


Subject(s)
Cytochrome P-450 Enzyme System , Sulfotransferases , Rats , Animals , Activation, Metabolic , Sulfotransferases/metabolism , Cytochrome P-450 Enzyme System/metabolism , Microsomes, Liver/metabolism , Glutathione/metabolism
3.
Chem Res Toxicol ; 35(9): 1493-1502, 2022 09 19.
Article in English | MEDLINE | ID: mdl-35994611

ABSTRACT

Omeprazole (OPZ) is a proton pump inhibitor commonly used for the treatment of gastric acid hypersecretion. Studies have revealed that use of OPZ can induce hepatotoxicity, but the mechanisms by which it induces liver injury are unclear. This study aimed to identify reactive metabolites of OPZ, determine the pathways of the metabolic activation, and define the correlation of the bioactivation with OPZ cytotoxicity. Quinone imine-derived glutathione (GSH), N-acetylcysteine (NAC), and cysteine (Cys) conjugates were detected in OPZ-fortified rat and human liver microsomal incubations captured with GSH, NAC, or Cys. The same GSH conjugates were detected in bile of rats and cultured liver primary cells after exposure to OPZ. Similarly, the same NAC conjugates were detected in urine of OPZ-treated rats. The resulting quinone imine was found to react with Cys residues of hepatic protein. CYP3A4 dominated the metabolic activation of OPZ. Exposure to OPZ resulted in decreased cell survival in cultured primary hepatocytes. Pretreatment with ketoconazole attenuated the susceptibility of hepatocytes to the cytotoxicity of OPZ.


Subject(s)
Cytochrome P-450 CYP3A , Omeprazole , Acetylcysteine/metabolism , Activation, Metabolic , Animals , Benzoquinones/metabolism , Cytochrome P-450 CYP3A/metabolism , Glutathione/metabolism , Humans , Imines/metabolism , Ketoconazole/metabolism , Microsomes, Liver/metabolism , Omeprazole/metabolism , Omeprazole/pharmacology , Proton Pump Inhibitors/metabolism , Rats
4.
Int J Biol Macromol ; 194: 763-769, 2022 Jan 01.
Article in English | MEDLINE | ID: mdl-34826452

ABSTRACT

A water-resistant polyamide-oxidized starch-methyl methacrylate (P-OS-M) adhesive with zero formaldehyde-emission was successfully synthesized, using natural corn starch, KMnO4, polyamide and methyl methacrylate as raw material, oxidant, crosslinking agent and comonomer, respectively. The P-OS-M25 adhesive synthesized with the optimal amount of methyl methacrylate (25 ml) could reach wet shear strength of 1.04 MPa, which was far greater than natural starch (NS) and oxidized starch (OS). Fourier transforms infrared spectrometer (FTIR) and X-ray diffraction (XRD) results showed that polyamide and methyl methacrylate were successfully cross-linked and copolymerized with oxidized starch. In addition, thermogravimetric analysis (TGA), rheology, scanning electron microscope (SEM) and contact angle respectively indicated that P-OS-M adhesive was suitable for wood adhesives in terms of thermal stability, viscosity, morphological and water resistence. These advantages increased the possibility of P-OS-M adhesive instead of petroleum-based wood adhesives.


Subject(s)
Adhesives/chemistry , Methylmethacrylate/chemistry , Starch/chemistry , Rheology , Shear Strength
SELECTION OF CITATIONS
SEARCH DETAIL
...